AGI Inc

Just hours before the listing, the company reduced the size of its offering and lowered its price range

AGI IPO: Brazilian smart bank goes public on NYSE

Kering SA

French luxury group Kering, which owns brands such as Gucci, Yves Saint Laurent, Bottega Veneta and Balenciaga, again reported a decline in sales last quarter. At the same time, it was less deep than analysts expected. At year-end, the company is also down 10%, but it expects a return to growth in 2026. The market took these results and forecasts positively: Kering shares rose sharply.

'This is not the year we wanted': Gucci owner reports sales slump, but shares soar

Oninvest correspondent interviewed the digital twin of the legendary investor about the recent gold collapse, the AI hype and portfolios for different occasions 

Oninvest has been testing Ray Dalio's AI-clone for two weeks. Here's what came out of it 

The Coca-Cola Company

McDonald's Corporation

Ferrari N.V.

This week, two crucial sets of economic data will be released in the United States - a rare coincidence caused by the recent government shutdown. First, the Bureau of Labor Statistics (BLS) will release its January employment report, followed by the Consumer Price Index. Thus, attention will be paid to both parts of the Federal Reserve's dual mandate: maximizing employment on the one hand and price stability on the other, Barron's <a href="https://www.barrons.com/articles/jobs-report-consumer-prices-coca-cola-cvs-ford-mcdonalds-earnings-7c16ca85?mod=RTA#:~:text=This%20week%20brings,will%20be%20covered.">notes</a>.

US inflation, Ferrari and Coca-Cola earnings: what investors need to know this week

Pfizer Inc.

Sanofi

AgomAb Therapeutics N.V. American Depositary Shares

Agomab's Crohn's disease therapy is already being clinically tested

Agomab Therapeutics IPO: Pfizer and Sanofi-backed biotech starts trading

Once Upon A Farm Pbc

The company is listed on the NYSE under the ticker OFRM

Once Upon a Farm IPO: Shares of Jennifer Garner-cofounded company start trading 

SpyGlass Pharma, Inc. Common Stock

Preliminary trading in shares of SpyGlass Pharma has begun on the Freedom customer trading system. This biotech startup is developing a system designed to reduce intraocular pressure in patients with glaucoma and cataracts. Later on February 6, the company's securities will appear on the Nasdaq exchange under the ticker <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a>. Click on the <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a> ticker to participate.

SpyGlass Pharma IPO: developer of eye disease therapy device goes public

On the night of Feb. 6, the value of bitcoin briefly approached $60,000 for the first time since October 2024

The crypto market is in a "phase of despair". Why does one strategist believe bitcoin will fall to zero?

Strategy Inc

Michael Burry warns that bitcoin's prolonged fall could unravel a "death spiral" that will lead to huge losses

Bitcoin has fallen below $70,000. An investor from the "Downgrade Game" - on how dangerous it is

Microsoft Corporation

Salesforce, Inc.

Adobe Inc.

One tool for lawyers has the market questioning the future of the entire Microsoft and Salesforce business model

Vazhnoe